Genetics of Alternative Transcript Abundance upon immune Cellular Activation
The human body is constantly exposed to infectious agents. Efficient immune response is therefore fundamental to protect the cells from infection and keep individuals healthy. Still, extreme variations are observed in the efficien...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EVOIMMUNOPOP
Human Evolutionary Immunogenomics population genetic variat...
1M€
Cerrado
THPLAST
The molecular regulation of T helper cell subtype plasticity...
211K€
Cerrado
Host-TB
Using CRISPR genome screens and dual transcriptome analyses...
2M€
Cerrado
IMMUNOGENE
Immunogenetics of Severe Bacterial Disease Susceptibility a...
2M€
Cerrado
REGVARMHC
Genetic and epigenetic determinants of allele specific gene...
1M€
Cerrado
ImmRisk
Defining how environmental factors influence downstream effe...
1M€
Cerrado
Información proyecto GATTACA
Duración del proyecto: 29 meses
Fecha Inicio: 2015-04-02
Fecha Fin: 2017-09-30
Líder del proyecto
INSTITUT PASTEUR
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
173K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The human body is constantly exposed to infectious agents. Efficient immune response is therefore fundamental to protect the cells from infection and keep individuals healthy. Still, extreme variations are observed in the efficiency of immune response among individuals and populations. Recently, the dissection of the genetic bases of the host immune response to infection has fostered a large interest in the scientific community. As a result, there is now a growing understanding of the influence of genetic variation on the transcriptional reprogramming of immune cells during infection. However, it is now widely accepted that the underlying ‘one gene–one protein’ paradigm is overly simplistic and cannot account for the full complexity of the transcriptome. Here, we propose to study how genetic variants affect transcript diversity to modulate the response to pathogens at the individual and population levels. To do so, we will seek to identify genetic variants that have conferred a selective advantage to human populations through modulation of isoforms usage in response to infection. This work will rely on an innovative strategy that combines coexpression-based studies of the isoform regulatory networks with analysis of the genetic determinants of splicing in response to infection. In doing so, this study should improve our understanding of isoform regulation and identify novel regulatory elements and splicing factor-target relationships in the specific context of infection.